
Alpa Laboratories Ltd
Past performance
About Alpa Laboratories Ltd Alpa Laboratories Limited, established in 1967 and incorporated in 1988, specializes in manufacturing pharmaceutical formulations such as liquid and dry injections, tablets, capsules, eye and ear drops, ointments, creams, and gels. Converted to a public limited company in 1998, Alpa Laboratories operates a manufacturing unit in Rau, Indore, which commenced commercial production in 1999. The company produces ethical, generic, over-the-counter (OTC), and veterinary drugs under its registered trademark "Alpa" and undertakes contract manufacturing for prominent pharmaceutical companies like Cipla and Zydus Cadila.
Alpa Laboratories' extensive product portfolio and marketing network cater to both domestic and international markets, including countries like the Philippines, Iran, and Kenya. The company is organized into four business divisions: Branded Generic, Veterinary, Exports, and Contract Manufacturing. Listed on the Bombay Stock Exchange and National Stock Exchange since 2008, Alpa expanded its operations with an oral solid dosage facility in 2012 and acquired Norfolk Mercantile Private Limited as a wholly-owned subsidiary in 2014-15.
Performance overview
